Relign Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Employees
-
35
- Latest Deal Type
-
M&A
Relign General Information
Description
Developer of an arthroscopic system intended to treat joint injuries. The company offers a system that utilizes a re-usable, sterilizable handle integrated with a single umbilical cable or conduit for cutting and removal of bone and soft tissue with an electrosurgical device, thereby enabling orthopedic surgeons to visualize, diagnose and treat problems inside a joint painlessly with cost-effectively.
Contact Information
Website
www.religncorp.comCorporate Office
- 655 Campbell Techology Parkway
- Suite 275
- Campbell, CA 95008
- United States
Corporate Office
- 655 Campbell Techology Parkway
- Suite 275
- Campbell, CA 95008
- United States
Relign Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 06-Nov-2020 | Completed | Generating Revenue | |||
| 4. Debt - PPP | 29-Apr-2020 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 15-Jun-2018 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 10-Dec-2015 | $6.6M | $13.1M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 15-May-2015 | $6.5M | $6.5M | Completed | Generating Revenue |
Relign Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 7,646,117 | $0.001000 | $0.07 | $0.9 | $0.9 | 1x | $0.9 | 18.28% |
Relign Comparisons
Industry
Financing
Details
Relign Competitors (1)
One of Relign’s competitors is Strauss Surgical, a Venture Capital-Backed company based in Miami, FL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Strauss Surgical | Venture Capital-Backed | Miami, FL |
Relign Patents
Relign Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026096264-A1 | Electro surgical device for total joint arthroplasty and other surgical applications | Pending | 01-Nov-2024 | ||
| US-20250241708-A1 | Surgical devices and methods for harvesting a graft from a tendon | Pending | 29-Jan-2024 | ||
| US-20250241654-A1 | Tourniquet control using visualization system | Pending | 29-Jan-2024 | ||
| US-20250114136-A1 | Electrosurgical devices and systems | Pending | 06-Oct-2023 | ||
| US-20250114122-A1 | Surgical visualization assembly and system | Pending | 06-Oct-2023 | A61B90/361 |
Relign Signals
Relign Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Medical Technology Venture Partners | Venture Capital | Minority | ||
| Synergy Ventures | Venture Capital | Minority |
Relign FAQs
-
When was Relign founded?
Relign was founded in 2011.
-
Where is Relign headquartered?
Relign is headquartered in Campbell, CA.
-
What is the size of Relign?
Relign has 35 total employees.
-
What industry is Relign in?
Relign’s primary industry is Surgical Devices.
-
Is Relign a private or public company?
Relign is a Private company.
-
What is Relign’s current revenue?
The current revenue for Relign is .
-
How much funding has Relign raised over time?
Relign has raised $43.2M.
-
Who are Relign’s investors?
Medical Technology Venture Partners and Synergy Ventures have invested in Relign.
-
Who are Relign’s competitors?
Strauss Surgical is a competitor of Relign.
-
When was Relign acquired?
Relign was acquired on 06-Nov-2020.
-
Who acquired Relign?
Relign was acquired by Zimmer Biomet Holdings.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process